Distinct Role of STAT3 and STAT5 Factors in MDS and AML

被引:1
|
作者
Fasouli, Eirini Sofia [1 ]
Giavi, Konstantina [1 ]
Makri, Charikleia [1 ]
Bystrykh, Leonid [2 ]
Bouchla, Anthi [3 ]
Athanasiadis, Emmanouil [1 ]
Vatsellas, Giannis [1 ]
Pappa, Vasiliki [4 ,5 ]
Katsantoni, Eleni [6 ]
机构
[1] Acad Athens, Biomed Res Fdn, Basic Res Ctr, Athens, Greece
[2] Univ Groningen, UMCG, Groningen, Netherlands
[3] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Dept Internal Med 2, Hematol Unit,Propaedeut & Res Unit,Sch Med, Athens, Greece
[4] Natl & Kapodistrian Univ Athens, Univ Gen Hosp Attikon, Dept Internal Med 2, Med Sch, Athens, Greece
[5] Natl & Kapodistrian Univ Athens, Univ Gen Hosp Attikon, Res Inst, Hematol Unit, Athens, Greece
[6] Acad Athens, Biomed Res Fdn, Athens, Greece
关键词
D O I
10.1182/blood-2023-185823
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [21] THROMBOPOIETIN (TPO) INDUCES TYROSINE PHOSPHORYLATION AND ACTIVATION OF STAT5 AND STAT3
    BACON, CM
    TORTOLANI, PJ
    SHIMOSAKA, A
    REES, RC
    LONGO, DL
    OSHEA, JJ
    FEBS LETTERS, 1995, 370 (1-2) : 63 - 68
  • [22] Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers
    Brachet-Botineau, Marie
    Polomski, Marion
    Neubauer, Heidi A.
    Juen, Ludovic
    Hedou, Damien
    Viaud-Massuard, Marie-Claude
    Prie, Gildas
    Gouilleux, Fabrice
    CANCERS, 2020, 12 (01)
  • [23] A preferential role for STAT5, not constitutively active STAT3, in promoting survival of a human lymphoid tumor
    Nagy, Zsuzsanna S.
    Rui, Hallgeir
    Stepkowski, Stanislaw M.
    Karras, James
    Kirken, Robert A.
    JOURNAL OF IMMUNOLOGY, 2006, 177 (08): : 5032 - 5040
  • [24] STAT3,STAT5靶向肿瘤治疗研究进展
    曹兵
    王鸿程
    国际内科学杂志, 2007, (09) : 518 - 520
  • [25] STAT3 and STAT5 regulations in gallic Acid & quercetin treated cells
    Gul, Huseyin
    Zergeroglu, Asuman Demiroglu
    ANTI-CANCER DRUGS, 2015, 26 : E27 - E27
  • [26] The Status of STAT3 and STAT5 in Human Breast Atypical Ductal Hyperplasia
    Shi, Aiping
    Dong, Jie
    Hilsenbeck, Susan
    Bi, Lirong
    Zhang, Hong
    Li, Yi
    PLOS ONE, 2015, 10 (07):
  • [27] Expressional STAT3/STAT5 Ratio is an Independent Prognostic Marker in Colon Carcinoma
    Klupp, Fee
    Diers, Johannes
    Kahlert, Christoph
    Neumann, Lena
    Halama, Niels
    Franz, Clemens
    Schmidt, Thomas
    Lasitschka, Felix
    Warth, Arne
    Weitz, Juergen
    Koch, Moritz
    Schneider, Martin
    Ulrich, Alexis
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S1548 - S1555
  • [28] Structural Implications of STAT3 and STAT5 SH2 Domain Mutations
    de Araujo, Elvin D.
    Orlova, Anna
    Neubauer, Heidi A.
    Bajusz, David
    Seo, Hyuk-Soo
    Dhe-Paganon, Sirano
    Keseru, Gyorgy M.
    Moriggl, Richard
    Gunning, Patrick T.
    CANCERS, 2019, 11 (11)
  • [29] Selective activation of STAT3 and STAT5 dictates the fate of myeloid progenitor cells
    Zhang, Meichao
    Meng, Yiling
    Ying, Yingxia
    Zhou, Pingting
    Zhang, Suning
    Fang, Yong
    Yao, Yuan
    Li, Dong
    CELL DEATH DISCOVERY, 2023, 9 (01)
  • [30] Selective activation of STAT3 and STAT5 dictates the fate of myeloid progenitor cells
    Meichao Zhang
    Yiling Meng
    Yingxia Ying
    Pingting Zhou
    Suning Zhang
    Yong Fang
    Yuan Yao
    Dong Li
    Cell Death Discovery, 9